Geleen, July 14, 2026 – Basic Pharma, based in Geleen, is entering its next phase of growth together with SHS Capital. The specialist German healthcare investor has acquired a majority stake in the company and brings financial strength, sector expertise and an international network to support the implementation of Basic Pharma’s existing strategic plan and the expansion of its production capacity. Basic Pharma will continue to operate under its own name, with the current management team remaining responsible for the company’s day-to-day leadership.